Why invest in Erothitan?
- High Grade of Medical Technology Products
- Great Market Potentials
-
Scientific and Technical Know-How
by Research Projects with Universities,
Research Institutes and European Commission - Patented Technology and Biomaterials
- Strategic Alliances
-
Focused Towards Biotechnology and
Nanotechnology - Continuous Growth in Demand
- Positive Cash Flow
Business Model
Research and Development
- EC Research Projects
-
National Research Projects
in Germany and Europe -
Cooperation with National
and International Universities
and RTD Performers - Industrial Partners
- National and International Patents
Products
- Orthopedic Implants
- Medical Devices in the Field of Incontinence
- Radolucent Surgery and Imaging Tables
Distribution
- Distributors and Agents
- Medical Product Advisors
- Direct Mailing
- E-Commerce
Our Corporate Identity
"The innovative Vision at the
Service of Human"
Vision
To Improve the Quality of Life
of Patients
Target Groups
- Hospitals and Clinics
- Medical Companies
- Industry
- Medical Service Agencies
- Pharmacies
Market Share per Market Segment
IPO Report
- Book-Building: 01.01.10 - 31.12.10
- Filing Date: 01.06.10
- Share Price: 6,25 - 7,50 Euro
Share Options
- Common Shares with min. 6% Dividend
- Preference Shares with min. 8% Dividend
- Single and Collected Documents
